DZ3367A1 - 2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS - Google Patents

2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS

Info

Publication number: DZ3367A1
Authority: DZ; Algeria
Prior art keywords: synthase inhibitors; aminothiazoline; derivatives; aminothiazoline derivatives; synthase
Prior art date: 2000-06-09

Application number

DZ013367A

Other languages

French (fr)

Inventor

Jean-Christophe Carry

Dominique Damour

Claude Guyon

Serge Mignani

Antony Bigot

Eric Bacque

Michel Tabart

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-09

Filing date

2001-06-07

Publication date

2001-12-13

2001-06-07 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2001-12-13 Application granted granted Critical

2001-12-13 Publication of DZ3367A1 publication Critical patent/DZ3367A1/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

DZ013367A 2000-06-09 2001-06-07 2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS DZ3367A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0007397A FR2810037B1 (en)	2000-06-09	2000-06-09	USE OF 2-AMINOTHIAZOLINE DERIVATIVES AS INDUCTIBLE NO-SYNTHASE INHIBITORS
PCT/FR2001/001760 WO2001094325A1 (en)	2000-06-09	2001-06-07	2-aminothiazoline derivatives and their use as no-synthase inhibitors

Publications (1)

Publication Number	Publication Date
DZ3367A1 true DZ3367A1 (en)	2001-12-13

Family

ID=8851134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ013367A DZ3367A1 (en)	2000-06-09	2001-06-07	2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS

Country Status (29)

Country	Link
EP (1)	EP1299365B1 (en)
JP (1)	JP4238026B2 (en)
KR (1)	KR20030025931A (en)
CN (1)	CN1202096C (en)
AP (1)	AP2002002708A0 (en)
AR (1)	AR029937A1 (en)
AT (1)	ATE305460T1 (en)
AU (1)	AU2001266124A1 (en)
BR (1)	BR0111986A (en)
CA (1)	CA2411760C (en)
DE (1)	DE60113689T2 (en)
DK (1)	DK1299365T3 (en)
DZ (1)	DZ3367A1 (en)
EA (1)	EA200300010A1 (en)
EC (1)	ECSP024375A (en)
ES (1)	ES2248347T3 (en)
FR (1)	FR2810037B1 (en)
HK (1)	HK1057900A1 (en)
HR (1)	HRP20020970A2 (en)
HU (1)	HUP0301000A2 (en)
IL (1)	IL153328A0 (en)
MA (1)	MA25814A1 (en)
MX (1)	MXPA02012071A (en)
NO (1)	NO20025884L (en)
NZ (1)	NZ522968A (en)
OA (1)	OA12286A (en)
PL (1)	PL360285A1 (en)
WO (1)	WO2001094325A1 (en)
ZA (1)	ZA200209769B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2337654T3 (en) *	2001-09-26	2010-04-28	Yissum Research Development Company Of The Hebrew University Of Jerusalem	SPHINGOLIPIDS.
BR0206354A (en) *	2001-11-09	2003-12-23	Aventis Pharma Sa	Use of 2-amino thiazoline derivatives as inducibly inducible synthase inhibitors
IL161843A0 (en) *	2001-11-09	2005-11-20	Aventis Pharma Sa	Use of 2-amino-4-pyridylmethyl-thiazoline dervatives as inhibitors of inducible no-synthase
MXPA04003766A (en) *	2001-11-09	2004-07-29	Aventis Pharma Sa	2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase.
AU2002238889A1 (en) *	2002-03-14	2003-09-22	Dainippon Pharmaceutical Co., Ltd.	Nitrogen monoxide synthase inhibitors
DK1539724T3 (en) *	2002-08-07	2008-02-11	Neuraxon Inc	Aminobenzothiazole compounds with NOS inhibitory activity
DE10332560B4 (en) *	2003-07-11	2010-07-08	Chiracon Gmbh	Process for the preparation of β-heteroaryl-2-alanine compounds via 2-amino-2- (heteroarylmethyl) -carboxylic acid compounds
KR101800507B1 (en)	2015-09-18	2018-01-18	주식회사 이엔이티아이	How to take advantage of the purification plants equipment and self-cleaning screen to clean up pollution by continue flowing sewage and process wastewater into the river

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5066662A (en) *	1990-05-21	1991-11-19	Warner-Lambert Company	Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
IL107771A0 (en) *	1992-11-27	1994-02-27	Wellcome Found	Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation
RU2136661C1 (en) *	1993-10-21	1999-09-10	Джи Ди Сирл энд Ко.	Amidino-derivatives, their use and pharmaceutical composition
AU4149696A (en) *	1994-11-15	1996-06-06	Merck & Co., Inc.	Substituted heterocycles as inhibitors of nitric oxide synthase
CA2395414A1 (en) *	1999-12-24	2001-07-05	Kyowa Hakko Kogyo Co., Ltd	Condensed purine derivative

2000
- 2000-06-09 FR FR0007397A patent/FR2810037B1/en not_active Expired - Fee Related
2001
- 2001-06-07 MX MXPA02012071A patent/MXPA02012071A/en active IP Right Grant
- 2001-06-07 AP APAP/P/2002/002708A patent/AP2002002708A0/en unknown
- 2001-06-07 DK DK01943580T patent/DK1299365T3/en active
- 2001-06-07 WO PCT/FR2001/001760 patent/WO2001094325A1/en active IP Right Grant
- 2001-06-07 CA CA002411760A patent/CA2411760C/en not_active Expired - Fee Related
- 2001-06-07 DE DE60113689T patent/DE60113689T2/en not_active Expired - Lifetime
- 2001-06-07 IL IL15332801A patent/IL153328A0/en unknown
- 2001-06-07 DZ DZ013367A patent/DZ3367A1/en active
- 2001-06-07 HU HU0301000A patent/HUP0301000A2/en unknown
- 2001-06-07 CN CNB01813386XA patent/CN1202096C/en not_active Expired - Fee Related
- 2001-06-07 AT AT01943580T patent/ATE305460T1/en not_active IP Right Cessation
- 2001-06-07 KR KR1020027016766A patent/KR20030025931A/en not_active Application Discontinuation
- 2001-06-07 EP EP01943580A patent/EP1299365B1/en not_active Expired - Lifetime
- 2001-06-07 EA EA200300010A patent/EA200300010A1/en unknown
- 2001-06-07 NZ NZ522968A patent/NZ522968A/en unknown
- 2001-06-07 AU AU2001266124A patent/AU2001266124A1/en not_active Abandoned
- 2001-06-07 AR ARP010102730A patent/AR029937A1/en not_active Application Discontinuation
- 2001-06-07 ES ES01943580T patent/ES2248347T3/en not_active Expired - Lifetime
- 2001-06-07 JP JP2002501875A patent/JP4238026B2/en not_active Expired - Fee Related
- 2001-06-07 BR BR0111986-9A patent/BR0111986A/en not_active Application Discontinuation
- 2001-06-07 PL PL36028501A patent/PL360285A1/en unknown
- 2001-06-07 OA OA1200200372A patent/OA12286A/en unknown
2002
- 2002-12-02 ZA ZA200209769A patent/ZA200209769B/en unknown
- 2002-12-06 HR HR20020970A patent/HRP20020970A2/en not_active Application Discontinuation
- 2002-12-06 NO NO20025884A patent/NO20025884L/en not_active Application Discontinuation
- 2002-12-09 EC EC2002004375A patent/ECSP024375A/en unknown
- 2002-12-09 MA MA26939A patent/MA25814A1/en unknown
2004
- 2004-02-06 HK HK04100771A patent/HK1057900A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP4238026B2 (en)	2009-03-11
HUP0301000A2 (en)	2003-08-28
OA12286A (en)	2006-05-12
HRP20020970A2 (en)	2005-02-28
EA200300010A1 (en)	2003-06-26
FR2810037A1 (en)	2001-12-14
IL153328A0 (en)	2003-07-06
EP1299365B1 (en)	2005-09-28
ZA200209769B (en)	2004-03-02
DE60113689T2 (en)	2006-07-13
AU2001266124A1 (en)	2001-12-17
BR0111986A (en)	2003-04-01
NO20025884L (en)	2003-01-29
CA2411760C (en)	2009-12-29
CN1202096C (en)	2005-05-18
ECSP024375A (en)	2003-02-06
CN1444572A (en)	2003-09-24
NZ522968A (en)	2005-07-29
FR2810037B1 (en)	2004-04-23
KR20030025931A (en)	2003-03-29
AP2002002708A0 (en)	2002-12-31
DK1299365T3 (en)	2006-02-06
JP2003535853A (en)	2003-12-02
WO2001094325A1 (en)	2001-12-13
MXPA02012071A (en)	2004-09-10
EP1299365A1 (en)	2003-04-09
ES2248347T3 (en)	2006-03-16
MA25814A1 (en)	2003-07-01
NO20025884D0 (en)	2002-12-06
HK1057900A1 (en)	2004-04-23
CA2411760A1 (en)	2001-12-13
PL360285A1 (en)	2004-09-06
AR029937A1 (en)	2003-07-23
DE60113689D1 (en)	2006-02-09
ATE305460T1 (en)	2005-10-15

Publication	Publication Date	Title
MA27001A1 (en)	2004-12-20	NOVEL SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS PHOSPHO-DIESTERASE-7 INHIBITORS
AR028576A1 (en)	2003-05-14	USEFUL B-CARBOLINE DERIVATIVES AS PHOSPHODESTERASE INHIBITORS
AR028575A1 (en)	2003-05-14	USED PIRROLOPIRIDINONE DERIVATIVES AS PHOSPHODESTERASE INHIBITORS
AR028253A1 (en)	2003-04-30	INHIBITORS OF THE GLUCOGENO FOSFORILASA
AR028567A1 (en)	2003-05-14	NEW DERIVATIVES OF FENIL-PROPARGILETER
EE200200715A (en)	2004-08-16	Substituted quinazoline derivatives and their use as inhibitors
PT1224195E (en)	2005-07-29	TGLS2 INHIBITOR C-ARYL-GLYCOSIDES
AR028596A1 (en)	2003-05-14	NEW DERIVATIVES OF PHENYLGLYCIN
PT1268480E (en)	2004-03-31	8-QUINOLINYL-XANTIN AND 8-ISOKINOLINYL-XANTIN DERIVATIVES AS PDE 5 INHIBITORS
DK1244647T3 (en)	2006-09-25	Quinzoline derivatives as VIGF inhibitors
ATE245142T1 (en)	2003-08-15	NO-SYNTHASE INHIBITORS
ATE437862T1 (en)	2009-08-15	PYRIMIDINE-5-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS
PT946512E (en)	2004-01-30	6-PHENYLPYRIDYL-2-AMINE DERIVATIVES AS US INHIBITORS
PT1194404E (en)	2006-08-31	ASPARTIL-PROTEASE INHIBITORS
NO20024997D0 (en)	2002-10-17	2-guanidino-4-arylquinazolines as NHE-3 inhibitors
PT1097127E (en)	2003-07-31	DIACYL-HYDRAZINE DERIVATIVES AS INTEGRIN INHIBITORS
DK1272488T3 (en)	2006-07-17	Tri-aryl-substituted ethane-PDE4 inhibitors
NO20016201D0 (en)	2001-12-18	Tienopyrimidines as phosphodiesterase inhibitors
NO20020873L (en)	2002-04-18	Removable absorbent article
EE200100371A (en)	2002-02-15	Amidinobenzylamine derivatives and their use as thrombin inhibitors
AR028068A1 (en)	2003-04-23	NEW DERIVATIVES OF 1,1-DIOXOTIOCROMANO AND ITS USE AS THROMBIN INHIBITORS
DZ3367A1 (en)	2001-12-13	2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS
PT1351959E (en)	2005-09-30	NEW PLEUROMUTILINE DERIVATIVES
PT1339695E (en)	2006-08-31	FARNESILTRANSFERASE INHIBITORS
ATE262517T1 (en)	2004-04-15	THIOPYRANE DERIVATIVES AS MMP INHIBITORS